| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $4.4M | — |
| R&D Expense | $28.8M | -39.4% |
| SG&A Expense | $61.6M | +48.0% |
| Interest Expense | $18.7M | +315.6% |
| Pre-tax Income | -$525.0M | -137.6% |
| Income Tax | $1.3M | -21.0% |
| Net Income | -$300.1M | -242.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $565.0M | +559.9% |
| Short-term Investments | $510.4M | +632.3% |
| Current Assets | $600.2M | +461.6% |
| Total Assets | $954.6M | +164.5% |
| Current Liabilities | $75.9M | +64.3% |
| Long-term Debt | $155.6M | +162.6% |
| Total Liabilities | $285.4M | +93.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$126.1M | +15.3% |
| Capital Expenditures | $174.1M | +46.6% |
| Investing Cash Flow | -$174.1M | -46.6% |
| Financing Cash Flow | $780.0M | +568.2% |
| Free Cash Flow | -$300.3M | -12.1% |
| Stockholders' Equity |
| $669.1M |
| +213.3% |